Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study. 2022

Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
GIGA-Cyclotron Research Center-In Vivo Imaging, University of Liège, 4000 Liege, Belgium.

Wheel-running exercise in laboratory rodents (animal model useful to study the neurobiology of aerobic exercise) decreases behavioural markers of vulnerability to addictive properties of various drugs of abuse including cocaine. However, neurobiological mechanisms underpinning this protective effect are far from fully characterized. Here, 28-day-old female C57BL/6J mice were housed with (n = 48) or without (n = 48) a running wheel for 6 weeks before being tested for acute locomotor responsiveness and initiation of locomotor sensitization to intraperitoneal injections of 8 mg/kg cocaine. The long-term expression of sensitization took place 3 weeks after the last session. On the day after, all mice underwent a micro-PET imaging session with [18F]fallypride radiotracer (dopamine 2/3 receptors antagonist). Exercised mice were less sensitive to acute and sensitized cocaine hyperlocomotor effects, such attenuation being particularly well marked for long-term expression of sensitization (η 2 P = 0.262). Chronic administration of cocaine was associated with a clear-cut increase of [18F]fallypride binding potential in mouse striatum (η 2 P = 0.170) while wheel-running exercise was associated with a moderate decrease in dopamine 2/3 receptors density in striatum (η 2 P = 0.075), a mechanism that might contribute to protective properties of exercise against drugs of abuse vulnerability.

UI MeSH Term Description Entries

Related Publications

Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
February 2014, Chemical communications (Cambridge, England),
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
March 2012, Neuroreport,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
October 2010, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
October 2012, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
August 2013, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
August 2006, Epilepsia,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
August 2008, The American journal of psychiatry,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
December 2013, Synapse (New York, N.Y.),
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
July 2011, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Guillaume Becker, and Louis-Ferdinand Lespine, and Mohamed Ali Bahri, and Maria Elisa Serrano, and Christian Lemaire, and André Luxen, and Ezio Tirelli, and Alain Plenevaux
May 2023, Endocrine,
Copied contents to your clipboard!